Douglas Drevets to Neurocysticercosis
This is a "connection" page, showing publications Douglas Drevets has written about Neurocysticercosis.
Connection Strength
1.127
-
Mass Spectrometry Identifies Taenia solium Proteins in Sera of Patients With and Without Parenchymal Neurocysticercosis. Parasite Immunol. 2024 Jul; 46(7):e13058.
Score: 0.233
-
Correlation between Monocyte Gene Expression and Inflammation on Brain Imaging in Patients with Solitary Cerebral Cysticercus Granuloma. Am J Trop Med Hyg. 2023 11 01; 109(5):992-998.
Score: 0.221
-
Imaging correlates of serum enzyme-linked immunoelectrotransfer blot (EITB) positivity in patients with parenchymal neurocysticercosis: results from 521 patients. Trans R Soc Trop Med Hyg. 2022 02 01; 116(2):117-123.
Score: 0.197
-
Distinguishing patients with idiopathic epilepsy from solitary cysticercus granuloma epilepsy and biochemical phenotype assessment using a serum biomolecule profiling platform. PLoS One. 2020; 15(8):e0237064.
Score: 0.178
-
Distinguishing neurocysticercosis epilepsy from epilepsy of unknown etiology using a minimal serum mass profiling platform. Exp Parasitol. 2018 Sep; 192:98-107.
Score: 0.155
-
Comparison of monocyte gene expression among patients with neurocysticercosis-associated epilepsy, Idiopathic Epilepsy and idiopathic headaches in India. PLoS Negl Trop Dis. 2017 Jun; 11(6):e0005664.
Score: 0.143